ResearchDx Appointment of New Chief Medical Officer to Meet NIH Push for Precision Medicine in Expediting “Bench to Bedside” Strategies for Disease Treatment

Irvine, CA—December 7, 2015—Internationally recognized as the “Contract Diagnostics Organization,” ResearchDx specializes in the development of companion and in vitro diagnostics for the pharmaceutical, biotechnology, research, and diagnostic industries. To meet the demand for leveraging new technology and increase the speed at which new treatments reach patients, life sciences firm ResearchDx has appointed Shelly Gunn […]

Read More